|
1TVB
Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2
Deposited 2004-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded
|
GOL GLYCEROL × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.216
|
|
1TVB
Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2
Deposited 2004-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded
|
GOL GLYCEROL × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.216
|
|
1TVH
Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2
Deposited 2004-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded
|
GOL GLYCEROL × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.247
|
|
1TVH
Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2
Deposited 2004-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
209–217(9 aa)
Fragment:residues 209-217
|
Not recorded
|
GOL GLYCEROL × 15
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;PEG 3350, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.80 Å
R-free 0.247
|
|
3CC5
H-2Db complex with human gp100
Deposited 2008-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
25–33(9 aa)
Fragment:Extracellular part, UNP residues 25-33
|
Not recorded
|
SO4 SULFATE ION × 2
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;10% PEG 6000, 0.1M Ammonium sulfate, 0.1M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.91 Å
R-free 0.268
|
|
3CC5
H-2Db complex with human gp100
Deposited 2008-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
25–33(9 aa)
Fragment:Extracellular part, UNP residues 25-33
|
Not recorded
|
SO4 SULFATE ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;10% PEG 6000, 0.1M Ammonium sulfate, 0.1M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.91 Å
R-free 0.268
|
|
4IS6
Crystal structure of HLA-DR4 bound to GP100 peptide
Deposited 2013-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
44–59(16 aa)
Fragment:UNP residues 44-59
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;PEG8000, magnesium chloride, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.50 Å
R-free 0.298
|
|
6VM7
SILv44 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV)
Deposited 2020-01-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Not recorded
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;16% v/v PEG3350, 280 mM ammonium citrate dibasic
|
Resolution 2.41 Å
R-free 0.241
|
|
6VM8
SILv44 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV)
Deposited 2020-01-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Mutation:T210M
|
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;20% v/v PEG3350, 236 mM ammonium citrate dibasic
|
Resolution 2.41 Å
R-free 0.221
|
|
6VM9
T4H2 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV)
Deposited 2020-01-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Mutation:T210M
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;18% v/v PEG10000, 16% v/v glycerol, 250 mM Tris pH 8.5, 60 mM sodium chloride, seeded with crushed crystals
|
Resolution 2.90 Å
R-free 0.250
|
|
6VMA
T4H2 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV)
Deposited 2020-01-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;18% v/v PEG10000, 16% v/v glycerol, 100 mM Tris pH 8.5, 100 mM sodium chloride
|
Resolution 2.75 Å
R-free 0.219
|
|
6VMC
T4H2 T cell receptor bound to HLA-A2 presenting gp100T2L peptide (ILDQVPFSV)
Deposited 2020-01-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
209–217(9 aa)
Fragment:epitope (UNP residues 209-217)
|
Mutation:T210L
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;18% v/v PEG10000, 16% v/v glycerol, 250 mM Tris pH 8.5, 60 mM sodium chloride
|
Resolution 2.85 Å
R-free 0.238
|
|
7PHR
Structure of a fully assembled T-cell receptor engaging a tumor-associated peptide-MHC I
Deposited 2021-08-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 11
PDB declaration: undecameric
|
Chain P
280–288(9 aa)
|
Mutation:A9V
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.08 Å
|
|
9JST
Wild-type native PMEL amyloid - polymorph 1
Deposited 2024-10-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
148–182(35 aa)
Chain B
148–182(35 aa)
Chain C
148–182(35 aa)
Chain D
148–182(35 aa)
Chain E
148–182(35 aa)
Chain F
148–182(35 aa)
Chain G
148–182(35 aa)
Chain H
148–182(35 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å
|
|
9JSU
Wild-type native PMEL amyloid - polymorph 2
Deposited 2024-10-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
151–183(33 aa)
Chain B
151–183(33 aa)
Chain C
151–183(33 aa)
Chain D
151–183(33 aa)
Chain E
151–183(33 aa)
Chain F
151–183(33 aa)
Chain G
151–183(33 aa)
Chain H
151–183(33 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å
|
|
9JSV
G175S mutant native PMEL amyloid
Deposited 2024-10-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
149–182(34 aa)
Chain B
149–182(34 aa)
Chain C
149–182(34 aa)
Chain D
149–182(34 aa)
Chain E
149–182(34 aa)
Chain F
149–182(34 aa)
Chain G
149–182(34 aa)
Chain H
149–182(34 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å
|
|
9JSW
Wild-type PMEL CAF amyloid -in vitro polymerized
Deposited 2024-10-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
148–182(35 aa)
Chain B
148–182(35 aa)
Chain C
148–182(35 aa)
Chain D
148–182(35 aa)
Chain E
148–182(35 aa)
Chain F
148–182(35 aa)
Chain G
148–182(35 aa)
Chain H
148–182(35 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.94 Å
|
|
9JSX
G175S PMEL CAF amyloid - in vitro polymerized
Deposited 2024-10-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
149–182(34 aa)
Chain B
149–182(34 aa)
Chain C
149–182(34 aa)
Chain D
149–182(34 aa)
Chain E
149–182(34 aa)
Chain F
149–182(34 aa)
Chain G
149–182(34 aa)
Chain H
149–182(34 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 4.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 1.79 Å
|